Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.61 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.51 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.51 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.51 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.49 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.49 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | RRM1 | P23921 | 1/20 | 0.46 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.46 |
| ▸ | LAP3 | P28838 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10271255 | 1.00 | ZDHHC7 (0.61) | ZDHHC7GNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL15708818 | 1.00 | ZDHHC7 (0.61) | ZDHHC7GNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL9828061 | 1.00 | ZDHHC7 (0.61) | ZDHHC7GNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL20447804 | 1.00 | ZDHHC7 (0.61) | ZDHHC7GNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL22551113 | 1.00 | ZDHHC7 (0.61) | ZDHHC7GNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL22551133 | 1.00 | ZDHHC7 (0.61) | ZDHHC7GNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL1064762 | 1.00 | ZDHHC7 (0.61) | ZDHHC7GNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL16007110 | 1.00 | ZDHHC7 (0.61) | ZDHHC7GNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL5135061 | 1.00 | ZDHHC7 (0.61) | ZDHHC7GNAI3GNAO1GNAI1DPP7 | |
| SCHEMBL29292342 | 1.00 | ZDHHC7 (0.61) | ZDHHC7GNAI3GNAO1GNAI1DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116470121-A | Low-temperature-resistant lithium battery | 广东嘉尚新能源科技有限公司 | 2023-07-21 | — | — | CN | disclosed |
| CN-105378486-A | Process for producing OMEGA-hydroxylated fatty acid derivatives | ABBOTT LAB | 2016-03-02 | — | — | CN | disclosed |
| US-20070014731-A1 | Contrast agents | GE HEALTHCARE | 2007-01-18 | — | — | US | disclosed |
| US-20040131548-A1 | Contrast agents | AMERSHAM HEALTH AS | 2004-07-08 | — | — | US | disclosed |
| US-20020172643-A1 | Contrast agents | NYCOMED IMAGING AS | 2002-11-21 | — | — | US | disclosed |
| EP-0576519-B1 | IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 2001-04-18 | — | — | EP | disclosed |
| US-6106806-A | DIAGNOTIC ULTRASOUND; BIODEGRADABLE | NYCOMED IMAGING AS (NO) | 2000-08-22 | — | — | US | disclosed |
| US-5567413-A | CONTRAST AGENT COMPRISING VESICLES OG PHOSPHOLIPID MATERIAL | NYCOMED IMAGING AS (NO) | 1996-10-22 | — | — | US | disclosed |
| US-5536490-A | ULTRASOUND OF VASCULAR SYSTEMS | NYCOMED IMAGING AS (NO) | 1996-07-16 | — | — | US | disclosed |
| EP-0576519-A1 | IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 1994-01-05 | — | — | EP | disclosed |
| WO-1992017212-A1 | IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS | HOLMES, MICHAEL, JOHN (GB) | 1992-10-15 | — | — | WO | disclosed |
| US-5132441-A | Amino acid derivatives | FUJI PHOTO FILM CO., LTD. (JP) | 1992-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070014731-A1 | Contrast agents | FABP3, ANXA4, ANXA5 | ZDHHC7 2235/4885GNAI3 1000/4885GNAO1 2084/4885 |
| US-20020172643-A1 | Contrast agents | FABP3, ANXA4, ANXA5 | ZDHHC7 2235/4885GNAI3 1000/4885GNAO1 2084/4885 |
| US-20040131548-A1 | Contrast agents | FABP3, ANXA4, ANXA5 | ZDHHC7 2235/4885GNAI3 1000/4885GNAO1 2084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.